Risk of Reactivation of Occult Hepatitis B in Cancer Patients During Immunotherapy.

Conditions: Occult Hepatitis B in Cancer Patients Interventions: Other: Observational: Blood sample of HVB-specific Elispot assay, HBSAg, HBV-DNA Sponsors: Fondazione IRCCS Policlinico San Matteo di Pavia Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials